These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2004-005078-22 Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions in p... bad-data
Reported results 2005-000040-85 Erbitux Monotherapie bei Patienten mit lokoregional nicht behandelbarem Hepatozellulären Karzinom 2008-01-31 due-trials
Reported results 2005-000774-46 BOne marrOw transfer to enhance ST-elevation infarct regeneration-2 2016-06-24 due-trials
Reported results Terminated 2005-001411-22 Serotonin-Transporter Binding in Tourette-Syndrome and Obsessive-Compulsive Disorder before and during Treatment with SRI: a I-123-ADAM-SPECT-Study 2013-07-31 due-trials
Reported results 2005-002634-35 Single centre, prospective, comparative, open-label, randomised study to evaluate the efficacy and tolerability of the combination of Moxifloxacin plus Metronidazole versus Piperacillin/Tazobactam for... 2012-07-07 due-trials
Reported results 2006-000673-30 Placebo kontrollierte Phase II Studie zur Therapie des fortgeschrittenen HCC mit Viscum fraxini 2016-01-20 due-trials
Reported results 2006-001407-11 A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolon and switch to low-dose ciclosporine A and everolimus without steroids in the prevention... 2010-05-18 due-trials
Reported results 2006-002546-11 Offene Phase IIIb Studie zur Elimination von CD4+CD25+ regulatorischen T-Zellen bei Patienten mit fortgeschrittenem HCC durch die Gabe von Cyclophosphamid 2008-11-24 due-trials
Not reported 2006-002962-20 Elimination of the preleukemic clone in children with Down syndrome and transient myeloproloferative disorder (TMD) to prevent AML - Model of leukemia prevention 2015-02-08 due-trials
Reported results Terminated 2007-000242-12 Monozentrische, prospektiv durchgeführte Studie zur Untersuchung der Pharmakokinetik von Voriconazol nach einmaliger und wiederholter Gabe von 2x4mg/kg pro Tag bei niereninsuffizienten Patienten mit G... 2009-09-08 due-trials
Reported results Terminated 2007-000506-78 Monozentrische, prospektive, offene Studie zur Untersuchung der „steady state“-Pharmakokinetik von Tigecyclin im Plasma, im ELF und in Alveolarmakrophagen bei Intensivpatienten mit tiefer Atemwegsinfe... 2008-07-22 due-trials
Reported results 2007-000517-10 Monozentrische, prospektiv durchgeführte Studie zur Untersuchung der „steady state“ - Pharmakokinetik von Caspofungin im Plasma, im ELF und in Alveolarmakrophagen bei beatmeten Intensivpatienten mit n... 2008-07-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-001200-20 A Multicenter, Randomized Phase II Trial Assessing the Activity of Gemcitabine – Oxaliplatin Chemotherapy Alone or in Combination with Cetuximab in Patients with Advanced Biliary Cancer 2010-07-27 bad-data
Not reported 2007-004517-34 Allogeneic stem cell transplantation for children, adolescents and young adults with relapsed or refractory AML 2021-02-24 due-trials
Reported results 2007-004611-61 Prospektive, randomisierte, monozentrische 2-armige Studie zum Einsatz von Daptomycin in der antibiotischen Prophylaxe von sternalen Wundinfektionen nach medianer Sternotomie 2012-03-12 due-trials
Reported results Terminated 2007-005503-17 Randomized multicenter double-blind study of phase III in patients after kidney transplantation with an acute cellular rejection with a tubulointerstinal component in kidney transplant with histologic... 2016-05-02 due-trials
Reported results Terminated 2008-000706-36 Optimization of treatment for patients with chronic hepatitis C infected with HCV-genotype 2 or 3: 12 vs. 24 weeks of treatment extension for patients without rapid virological response 2013-08-05 due-trials
Reported results 2008-000766-23 Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study- 2010-08-25 due-trials
Reported results Terminated 2008-002338-31 Prospektive randomisierte Phase II Studie zur Behandlung von Patienten mit fortgeschrittenem hormonrefraktären Prostatakarzinom mittels LHRH-Analoga und Somatostatin-Analoga unter Berücksichtigung der... 2011-06-30 due-trials
Reported results 2008-005433-30 Taxotere-Enoxaparin-(ENOXA)-Studie: 1st-Line Docetaxel-Platin Chemotherapie alleine oder in Kombination mit Enoxaparin bei Patienten mit lokal fortgeschrittenem oder metastasiertem nicht-kleinzelligem... 2011-03-28 due-trials
Reported results 2008-005560-13 A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interfeorn-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis- The Hep... 2017-08-02 due-trials
Reported results 2008-005862-30 Pre-emptive therapy of acute graft versus host disease according to specific proteomic patterns after allogeneic hematopoietic stem cell transplantation. 2015-12-07 due-trials
Reported results Terminated 2008-005925-12 Polyomavirus BK nephropathy after renal transplantation: Randomized clinical trial to demonstrate that switching to mTOR inhibitor is more effective than a reduction of immunosuppressive therapy 2020-07-23 due-trials
Reported results 2008-005976-28 Prevention of HBV reinfection after liver transplantation using entecavir monotherapy after short-term HBIg administration: A pilot study Version 1.2 2008-09-11 Amendment 2 2009-07-07 2015-10-26 due-trials
Reported results Terminated 2009-011324-60 Prospective randomized trial to compare a twice daily to a once daily administration of the Tacrolimus in lung transplanted patients 2012-07-02 due-trials
Reported results 2009-012436-32 A multicenter, randomized, open-labeled study to steer immunsuppressive and antiviral therapy by measurement of virus- (CMV, ADV, HSV) specific T cells in addition to determination of trough levels of... 2019-03-26 due-trials
Reported results 2009-014383-18 A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer 2014-03-14 due-trials
Reported results 2009-014396-43 A single arm, open-label multicenter phase II trial of temsirolimus in patients with relapsed/ recurrent squamous cell cancer of the Head and Neck (HNSCC) 2012-03-12 due-trials
Reported results 2009-015125-36 Clostridium botulinum Typ A Neurotoxinkomplex zur adjuvanten Behandlung von depressiven Störungen – Eine randomisierte, kontrollierte Pilotstudie 2011-12-31 due-trials
Reported results 2009-017052-27 A Phase II Study to Evaluate the Immunogenicity, Safety and Tolerability of a H1N1 Influenza Vaccine in Immunocompromised Adults Who Have Undergone Solid Organ Transplantation or Bone Marrow Transplan... 2011-04-30 due-trials
Not reported 2010-018850-11 Panitumumab in combination with cisplatin/gemcitabine chemotherapy in patients with cholangiocarcinomas - a randomized clinical phase II study - PiCCA Study 2015-12-15 due-trials
Listed as ongoing, but also has a completion date 2010-018980-41 International randomized phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia 2020-08-01 bad-data
Exempt 2010-021719-18 Phase I/II study on cytarabine and idarubicine combined with escalating doses of clofarabine as induction therapy in patients with acute myeloid leukemia and high risk for induction failure (CIARA) 2016-02-23 not-yet-due
Reported results 2010-021944-17 Randomized, Multi-centre, Phase II Trial to compare the Event-Free Survival of Clofarabine / Ara-C (ClAraC) or of FLAMSA Treatment in Patients with High Risk AML or Advanced MDS scheduled for Allogene... 2017-05-15 due-trials
Reported results 2010-022871-78 A Phase II Study to Evaluate the Immunogenicity, Safety and Tolerability of a Seasonal Influenza Vaccine including H1N1 in Immunocompromised Adults Who Have Undergone Solid Organ Transplantation or Bo... 2012-03-06 due-trials
Reported results 2011-004168-30 A randomized phase II trial comparing pazopanib with doxorubicin as first line treatment in elderly patients with metastatic or advanced soft tissue sarcoma 2017-03-10 due-trials
Reported results 2012-001352-19 BE-RELACs-Trial: Biomarkers Explaining RELevance of ACute Rejections 2017-06-06 due-trials
Reported results Terminated 2012-003234-16 Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD – The ABACOPD Study 2019-06-05 due-trials
Reported results Terminated 2012-005002-22 ACEMg mediated hearing preservation in cochlear implant patients receiving different electrode lengths 2016-06-15 due-trials
Reported results 2013-001081-42 Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection with Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study 2016-06-13 due-trials
Reported results 2013-002825-52 Single-center, open-label, single-arm Phase IIa study in kidney transplant patients with acute T-cell-mediated rejection in renal transplant according to Banff criteria (class IA and IB) without (stag... 2015-06-19 due-trials
Ongoing 2013-005326-38 A multicenter, randomized, double-blind, placebo-controlled study to demonstrate that digitoxin reduces a composite of overall mortality and hospitalization for worsening heart failure in patients wit... not-yet-due
Reported results Terminated 2014-003313-28 SGLT2 inhibition with empagliflozin in patients with type 2 diabetes mellitus: Influences on left ventricular mass, function, and cardiac lipid content (EMPATROPHY) 2018-06-29 due-trials
Reported results 2015-000749-21 Botulinumtoxin A for emotional stabilization in borderline personality disorder Botulinumtoxin A zur emotionalen Stabilisierung bei der Borderline-Persönlichkeitsstörung 2019-05-10 due-trials
Reported results 2016-000564-42 A randomized multi-centre double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders (CANNA-TICS) Randomisiert... 2020-11-20 due-trials
Reported results Terminated 2016-000825-38 SGLT2-inhibition with Empagliflozin reduces progression of diabetic retinopathy in patients with high risk of diabetic macular edema (The SUPER-Trial) 2018-09-18 due-trials
Reported results 2016-005100-26 A pilot Study to explore safety, tolerability and efficacy of ORal IrON supplementation with ferric maltol in treating iron deficiency in patients with pulmonary hypertension and iron deficiency anemi... 2020-03-19 due-trials
Reported results 2016-005101-39 A phase IV study to explore the safety of ORal IrON supplementation with ferric maltol in treating iron deficiency in patients with heart failure carrying Left Ventricular Assist Devices (ORION-LVAD-1... 2019-11-29 due-trials
Reported results Terminated 2017-000394-36 Influences of angiotensin-neprilysin inhibition with Sacubitril/Valsartan (ENTRESTO®) on centrally generated sympathetic activity in heart failure patients 2018-09-06 due-trials
Reported results 2017-000403-24 HepNet pilot trial: Multicenter trial for the treatment of chronic hepatitis E with sofosbuvir (SofE) 2019-02-18 due-trials
Reported results 2018-003474-27 Multicenter trial for the treatment of acute Hepatitis C for 8 weeks with Sofosbuvir/Velpatasvir fix dose combination - The HepNet Acute HCV-V study 2021-06-08 due-trials
Reported results Terminated 2020-001936-86 A prospective, randomized, open label Phase 2 clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19 2021-11-15 due-trials
Ongoing 2021-000130-33 A pilot study to explore safety, tolerability and efficacy of ORal IrON supplementation with ferric maltol in treating iron deficiency and anaemia in patients with Heart Failure (ORION-HF) not-yet-due
Ongoing 2021-005362-18 Hepatitis B immunoglobulins to induce HBsAg clearance in patients with chronic hepatitis B not-yet-due
Exempt 2021-006895-17 Phase Ia/IIb study of PHD inhibitor molidustat in combination with IDH1 inhibitor ivosidenib in IDH1-mutated relapsed/refractory AML or MDS/AML patients not-yet-due
Ongoing 2022-003526-50 A prospective, interventional, single-center, single-arm study to assess the effectiveness of Bempedoic acid to achieve LDL-cholesterol targets in patients following ST-elevation or Non-ST-elevation m... not-yet-due